Bone Anabolic Agents
- Name
- Bone Anabolic Agents
- Accession Number
- DBCAT004660
- Description
Not Available
- Drugs
Drug Drug Description Teriparatide A recombinant parathyroid hormone used for the treatment of osteoporosis. Romosozumab A monoclonal antibody used to treat osteoporosis in postmenopausal women at high risk of fracture, patients who are intolerant of other treatments, or patients who have failed other treatments. - Drugs & Drug Targets
Drug Target Type Teriparatide Parathyroid hormone/parathyroid hormone-related peptide receptor target Romosozumab Sclerostin target